Slice of Healthcare

Join us on the latest episode! Our Guest: Javier Swarcberg, CEO of Spruce Biosciences

What you'll get out of this episode:
  • Dive deep into the world of Congenital Adrenal Hyperplasia (CAH) treatments and drug development.
  • Understand the challenges and rewards of addressing rare diseases, especially in pediatrics.
  • Javier Szwarcberg discusses Spruce's innovative Tildesophon and its potential impact on the CAH therapeutic landscape.
  • Discover the upcoming clinical updates from Spruce Biosciences and the promising future outlook for CH treatments.

To learn more about Spruce Biosciences: https://sprucebio.com/

Our sponsors for this episode are:
Sage Growth Partners https://sage-growth.com/

What is Slice of Healthcare?

The go-to site for digital health executive/provider interviews, technology updates, and industry news. Listed to in 65+ countries. Sponsored by Sage Growth Partners and Quantum Health.